Cardiovascular Magnetic Resonance in Adults With SysTemic Right Ventricle (STAR)
STAR
1 other identifier
observational
30
1 country
1
Brief Summary
The main aim of the study is to explore HFs in SRV, comparing their magnitude and direction with that of subpulmonary RV and systemic LV. As a secondary aim, possible association or correlation will be investigated between SRV energetics and: i) patient functional parameters, e.g., the results from cardiopulmonary exercise test (CPET), ii) patient clinical status, including the occurrence of adverse outcome (a composite of death, hospitalization for heart failure, cardiovascular arrest, sustained arrhythmias).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2022
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 29, 2022
CompletedFirst Submitted
Initial submission to the registry
January 10, 2023
CompletedFirst Posted
Study publicly available on registry
January 19, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedJanuary 25, 2023
January 1, 2023
2.6 years
January 10, 2023
January 20, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Adverse Outcome definition
A composite of death, hospitalizations for heart failure, cardiovascular arrest, sustained arrhythmias (≥30 seconds).
5 years
Study Arms (2)
Case
The study will include patients aged ≥ 18 years with the diagnosis of L-TGA and D-TGA, who: * are admitted to IRCCS Policlinico San Donato, the Adult Congenital Heart Unit or * are scheduled for a Cardiovascular Magnetic Resonance examination in this Institution
Control
The study will include subjects aged ≥ 18 years who will invited for a Cardiovascular Magnetic Resonance examination in our Institution. This group of control will include n=15 of adult healthy subjects. A further inclusion criteria for the control subjects are age and male proportion comparable to those of the TGA group.
Eligibility Criteria
Patients with diagnosis of L-loop transposition of great arteries (L-TGA) and D-loop transposition of great arteries (D-TGA) after atrial switch operation (ASO).
You may qualify if:
- The study will include patients aged ≥ 18 years with the diagnosis of L-TGA and D-TGA, who:
- are admitted to UNICCA, the Adult Congenital Heart Unit or
- are scheduled for a Cardiovascular Magnetic Resonance examination in this Institution
- Control group:
You may not qualify if:
- (case and control group)
- Subjects with intrabody ferromagnetic material precluding subject's safety
- Subjects with non CMR-conditional devices
- Subjects with claustrophobia or breath-holding precluding an adequate CMR and 4D Flow images quality
- Pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IRCCS Policlinico San Donato
San Donato Milanese, Milano, 20097, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 10, 2023
First Posted
January 19, 2023
Study Start
November 29, 2022
Primary Completion
June 30, 2025
Study Completion
June 30, 2025
Last Updated
January 25, 2023
Record last verified: 2023-01